Login

Gianmarco Orgnoni, COO of Vection Technologies (ASX: VR1), joins ASX Investor Channel to discuss company developments and strategies. 00:10:00

Share On Facebook Share On Twitter

Gianmarco Biagi is the CEO of Vection Technologies.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Exploration Potential of E2 Gold's Hawkins Project in Ontario, Canada
00:10:00
Invests in software companies across all stages|Asheem Chandna,Partner,Greylock
00:10:00
"Navigating Opportunities and Risks in Performing Credit: Armen Panossian and Danielle Poli Reflect on 2020 and Look Ahead in Oaktree's 'Insights Live' Series"
00:10:00
Jonathan Satchell, CEO of Learning Technologies Group PLC, discusses the company's half-year results for the six months ended 30 June 2021 in an interview with Proactive.
00:10:00
Believes that creating something of true significance|Gigi Levy-Weiss,General Partner,NFX
00:10:00
Streamlining Complexity: A Testimonial of Mentoring and Alignment | Arthur Oginga, CEO ,  UAP Old Mutual Holdings.
00:10:00
Kimberly Ann Discusses Lahontan Gold's Projects and Mining's Future
00:10:00
Introducing Gerald Pötzsch, the new CEO of ContextVision, discussing his decision to join the company and what makes ContextVision a standout in its field.|Gerald Pötzsch joined ContextVision in August 2022 as CEO.
00:10:00
In-Depth Discussion on Working Capital with Mark Kenney, CEO of CAPREIT|CEO,Canadian Apartment Properties Real Estate Investment Trust
00:10:00
Air France-KLM CEO Benjamin Smith on Summer Readiness and Optimism | Benjamin Smith, CEO, Air France-KLM .
00:10:00
Millennium Investment's Focus on Activated Carbon for Energy Storage
00:10:00
Banking on Opportunity: A Look Ahead with Dinesh Khara | Dinesh Kumar Khara, Chairman , State Bank of India.

© 2026 Nehu